Immunic is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.
AdWant To Stay Updated? Latest News To Give You The Tools To Invest Smarter. Give Yourself the Resources to Pull Ahead. Try Premium for Just $4.95 For Your First Month
Independent Authors · Invest with Confidence · Compare Your Stocks · Alpha Picks